Rigel Pharmaceuticals on Thursday said the U.S. Food and Drug Administration granted orphan-drug designation to its proposed R289 treatment for myelodysplastic syndromes, a group of rare blood cancers ...
The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...
Protein powders may contain high levels of lead and cadmium, with chocolate-flavored and plant-based products testing at the ...
The popular seed oil is known for its high smoke point and neutral flavor that make it ideal for frying or baking. Here’s how ...
Costco, the retail giant known for its bulk goods and beloved Kirkland brand, has initiated a recall of its Kirkland Si ...
Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...
A Washington state-based nonprofit has launched a program training pharmacists to prescribe abortion medications via ...
Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) is pleased to announce amendments to its Manufacturing Services Agreement with CytoImmune Therapeutics ...